EVAX ▼ -1.4% - Evaxion A/S
$EVAX - Evaxion to present broad biomarker data from phase 2 trial with personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting
03-NOV-2026 09:00 AM ET
Share this post
More filings for $EVAX
EVAX ▼ -2.3% - Evaxion A/SOct 30, 2026EVAX ▼ -2.2% - Evaxion A/SOct 23, 2026EVAX ▲ +15.7% - Evaxion A/SOct 19, 2026EVAX ▲ +4.1% - Evaxion A/SOct 2, 2026EVAX ▲ +1.9% - Evaxion A/SSep 14, 2026
View full $EVAX filing history →💬 Comments
Loading comments…
Leave a comment